Items | NFgroup | n | Control group | n | p |
---|---|---|---|---|---|
 Number of patient | 15 |  | 14 |  |  |
 Sex (male/female) | 9/6 | 15 | 11/3 | 14 | n.s.a |
 Age (year) | 76.1 ± 5.0 (70.0–87.0) | 15 | 74.7 ± 4.2 (70.0–87.0) | 14 | n.s.b |
 Dialysis vintage (year) | 9.8 ± 9.1 (0.5–30.0) | 15 | 6.5 ± 4.2 (1.0–13.0) | 14 | n.s.c |
 Dry weight (kg) | 52.0 ± 9.1 (33.8–63.5) | 15 | 57.8 ± 11.4 (43.2–90.0) | 14 | n.s. b |
 Albumin concentration before dialysis (g/dL) | 3.7 ± 0.3 (3.1–4.0) | 15 | 3.6 ± 0.2 (3.3–4.1) | 13 | n.s. b |
Dialysis condition | Â | Â | Â | Â | Â |
 Blood flow rate (mL/min) | 217.3 ± 28.4 (200–300) | 15 | 220.0 ± 22.2 (200–250) | 14 | n.s. b |
 Dialysis time (h) | 4.1 ± 0.3 (4.0–5.0) | 15 | 4.1 ± 0.3 (4.0–5.0) | 14 | n.s. b |
 Effective surface area (m2) | 1.7 ± 0.3 (1.3–2.1) | 15 | 1.8 ± 0.3 (1.5–2.1) | 14 | n.s. b |
 Dialysis membrane (PS/PES/PEPA) | (8/5/2) | 15 | (12/1/1) | 14 | n.s. a |
 Classification of dialyzer# (I·II/III/IV/V) | (0/0/8/7) | 15 | (0/4/5/5) | 14 | n.s. a |
 Dialysate (with acetate/without acetate) | (9/6) | 15 | (13/1) | 14 | p < 0.05 a |
Medical history | Â | Â | Â | Â | Â |
 Diabetes mellitus (Y/N) | (6/9) | 15 | (3/11) | 14 | n.s. a |
 Cerebrocardiovascular event (Y/N) | (3/12) | 15 | (4/10) | 14 | n.s. a |